The 16 most recent market catalysts affecting $IRTC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 17, 2026
Corporate Catalyst
Bullish
Impact 65
iRhythm Enters $100 Million Accelerated Share Repurchase Agreement
iRhythm Holdings, Inc. announced a $100 million accelerated share repurchase agreement, utilizing existing cash. This ASR is a significant portion of their previously authorized $2…
Nov 6, 2026
Corporate Catalyst
Bearish
Impact 95
iRhythm Technologies Faces Investor Investigation Following Q3 Earnings Miss and Guidance Update
iRhythm Technologies (IRTC) announced disappointing Q3 2026 financial results, missing analyst revenue estimates and reporting flat year-over-year sales for its key Zio AT product.…
Nov 6, 2026
Corporate Catalyst
Neutral
Impact 65
Analyst Actions: BTIG, Needham, and Truist Securities Adjust iRhythm Price Targets
On November 6, 2026, BTIG, Needham, and Truist Securities all reduced their price targets for iRhythm Holdings (IRTC), although they maintained their 'Buy' ratings. This collective…
Nov 6, 2026
Corporate Catalyst
Bullish
Impact 65
Needham Lowers Price Target on iRhythm Technologies
Needham has lowered its price target for iRhythm Technologies (IRTC) from $194 to $165. This action signals a more cautious valuation from the analyst, potentially due to revised g…
Nov 5, 2026
Corporate Catalyst
Neutral
Impact 92
iRhythm Holdings, Inc. Reports Third Quarter 2026 Financial Results
iRhythm Holdings reported strong third-quarter 2026 financial results, with revenue increasing by 14.9% year-over-year and a significant improvement in gross margin. The company al…
Oct 16, 2026
Corporate Catalyst
Neutral
Impact 65
Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
Piper Sandler analyst Adam Maeder has initiated coverage on iRhythm Holdings (IRTC) with an 'Overweight' rating and a $160 price target. This is a significant event for IRTC as new…
Aug 18, 2026
Corporate Catalyst
Bearish
Impact 55
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck updated his coverage on iRhythm Holdings, maintaining an 'Overweight' rating but reducing the price target from $180 to $168. This adjustment su…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168
Truist Securities analyst Richard Newitter maintained a 'Buy' rating on iRhythm Holdings and raised the price target from $160 to $168. This action signals continued bullish sentim…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 92
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
iRhythm Holdings, Inc. is acquiring VitalConnect, a developer of wearable biosensor technology, for $287.5 million. This acquisition is a significant strategic move for iRhythm, br…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck maintained an 'Overweight' rating on iRhythm Holdings (IRTC), signaling continued confidence in the company's long-term prospects. However, the …
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Evercore ISI Group Maintains Outperform on iRhythm Holdings, Raises Price Target to $165
Evercore ISI Group analyst Vijay Kumar has maintained an 'Outperform' rating on iRhythm Holdings (IRTC) and raised the price target from $150 to $165. This upgrade signals increase…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
iRhythm To Acquire Maker Of Wearable Biosensor And Ambulatory Cardiac Monitoring Technology Vital Connect For ~$237.5M In Cash And ~$50M In IRTC Stock
iRhythm Technologies (IRTC) is acquiring VitalConnect, a maker of wearable biosensors and ambulatory cardiac monitoring technology, for $287.5 million. This acquisition is a signif…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M Est
iRhythm Holdings (IRTC) announced an upward revision to its fiscal year 2026 sales guidance, increasing the lower bound by $5 million and the upper bound by $5 million. This indica…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 95
iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate
iRhythm Technologies announced impressive Q2 results, with adjusted EPS of $0.58 significantly surpassing the $(0.00) estimate and sales of $224.172 million beating the $219.324 mi…
Jul 23, 2026
Corporate Catalyst
Neutral
Impact 55
Stephens & Co. Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
Stephens & Co. analyst Mason Carrico has initiated coverage on iRhythm Holdings (IRTC) with an 'Overweight' rating and a price target of $160. This event is significant as new anal…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.